Growth Metrics

Astrana Health (ASTH) Operating Leases (2019 - 2025)

Astrana Health (ASTH) has disclosed Operating Leases for 7 consecutive years, with $31.6 million as the latest value for Q4 2025.

  • Quarterly Operating Leases rose 2.93% to $31.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $31.6 million through Dec 2025, up 2.93% year-over-year, with the annual reading at $31.6 million for FY2025, 2.93% up from the prior year.
  • Operating Leases hit $31.6 million in Q4 2025 for Astrana Health, up from $30.2 million in the prior quarter.
  • In the past five years, Operating Leases ranged from a high of $42.7 million in Q1 2024 to a low of $12.6 million in Q1 2022.
  • Historically, Operating Leases has averaged $23.9 million across 5 years, with a median of $22.2 million in 2022.
  • Biggest five-year swings in Operating Leases: skyrocketed 135.21% in 2024 and later plummeted 32.21% in 2025.
  • Year by year, Operating Leases stood at $13.2 million in 2021, then surged by 50.89% to $19.9 million in 2022, then surged by 82.22% to $36.3 million in 2023, then dropped by 15.53% to $30.7 million in 2024, then rose by 2.93% to $31.6 million in 2025.
  • Business Quant data shows Operating Leases for ASTH at $31.6 million in Q4 2025, $30.2 million in Q3 2025, and $28.7 million in Q2 2025.